Susquehanna International Group’s YieldMax MRNA Option Income Strategy ETF MRNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.01M Buy
+54,160
New +$1.02M ﹤0.01% 7865
2025
Q4
Sell
-21,091
Closed -$373K 13133
2025
Q3
$373K Buy
+21,091
New +$437K ﹤0.01% 9622
2025
Q2
Sell
-9,773
Closed -$270K 13333
2025
Q1
$270K Buy
9,773
+5,459
+127% +$210K ﹤0.01% 10297
2024
Q4
$227K Buy
4,314
+3,090
+252% +$193K ﹤0.01% 10447
2024
Q3
$108K Sell
1,224
-780
-39% -$92.9K ﹤0.01% 11004
2024
Q2
$309K Buy
+2,004
New +$395K ﹤0.01% 9374

Other funds holding MRNY

Susquehanna International Group's MRNY Position: Q1 2026 in Review

Susquehanna International Group opened a new position in YieldMax MRNA Option Income Strategy ETF (MRNY) in Q1 2026: 54,160 shares worth $1.01M. The stake represents ﹤0.01% of the portfolio and ranks #7865 among its holdings. This is a return to the name: Susquehanna International Group previously reported a position in MRNY as recently as Q3 2025.

Susquehanna International Group first reported a position in MRNY in Q2 2024 and has held it in 6 quarters since. 11 funds tracked by Wall St. Rank hold MRNY as of Q1 2026.

  • Susquehanna International Group held 54,160 shares of YieldMax MRNA Option Income Strategy ETF worth $1.01M as of Q1 2026.
  • YieldMax MRNA Option Income Strategy ETF was a new Susquehanna International Group position in Q1 2026.
  • YieldMax MRNA Option Income Strategy ETF made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #7865 holding.
  • Susquehanna International Group first reported a position in YieldMax MRNA Option Income Strategy ETF in Q2 2024 and has held it in 6 quarters since.
  • 11 funds tracked by Wall St. Rank held YieldMax MRNA Option Income Strategy ETF as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.